tm logo

Monitor this mark

View On USPTO

ZARXIO
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 10 Jun 2022

Last Applicant/ Owned by

SANDOZ AG

VIADUKTSTRASSE 3

BASEL

CH

4051

Serial Number

86242357 filed on 04th Apr 2014

Registration Number

4886448 registered on 12th Jan 2016

in the Principal Register

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III

3724 BENSON DR

RALEIGH NC 27609-7321

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

ZARXIO

Pharmaceutical preparations for use in stimulating white blood cell production available only by prescription

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for use in stimulating white blood cell production available only by prescription

First Use Date in General

03rd Sep 2015

First Use Date in Commerce

03rd Sep 2015

Mark Details

Serial Number

No 86242357

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

01.15.08 -

A single drop (including a single raindrop or a single teardrop)

Legal History

Show more

Status DateAction Taken
06th Dec 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10th Jun 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Jun 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10th Jun 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
21st Dec 2021TEAS SECTION 8 & 15 RECEIVED
12th Jan 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12th Jan 2016REGISTERED-PRINCIPAL REGISTER
08th Dec 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07th Dec 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04th Dec 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED